CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onUpstream position: supplies 8 industries, depends on 0
- ScaleRevenue is $37.92B, higher than 95% of all stocks globally
- PositionGross margin is 1.1%, lower than 95% of its Conglomerates peers (median 26.3%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.11%Below 5Y avg (4.46%)
Annual Rate
CNY 0.13Paid annual
Payout Ratio
44.8%Sustainable
Payback Period
47.0 yr
Last Ex-Dividend
Jun 5, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
4.36BCNY651.00M · vs all stocks (USD)
Trailing P/E
21.28xvs Conglomerates peers
Revenue (TTM)
254.24BCNY37.92B · vs all stocks (USD)
Profit Margin
0.10%vs Conglomerates peers
Beta
0.5510xvs all stocks
52-Week Change
1.15%vs all stocks
Market Capitalization
4.36BCNY651.00M · vs all stocks (USD)
Enterprise Value
15.44BCNY2.30B · vs all stocks (USD)
Trailing P/E
21.28xvs Conglomerates peers
Forward P/E
5.77xvs Conglomerates peers
PEG Ratio
-1.84xvs Conglomerates peers
Price to Sales (TTM)
0.0172xvs Conglomerates peers
Price to Book (MRQ)
0.8934xvs Conglomerates peers
Enterprise to Revenue
0.0610xvs Conglomerates peers
Enterprise to EBITDA
10.87xvs Conglomerates peers
Gross Margin
1.12%vs Conglomerates peers
Profit Margin
0.10%vs Conglomerates peers
Operating Margin
0.57%vs Conglomerates peers
Return on Assets (TTM)
1.50%vs Conglomerates peers
Return on Equity (TTM)
6.31%vs Conglomerates peers
Revenue (TTM)
254.24BCNY37.92B · vs all stocks (USD)
Revenue per Share (TTM)
341.27CNYUpdated Sep 19, 2026Quarterly Revenue Growth
23.70%vs Conglomerates peers
Gross Profit (TTM)
2.81BCNY418.72M · vs all stocks (USD)
EBITDA (TTM)
1.41BCNY210.17M · vs all stocks (USD)
Net Income (TTM)
229.37MCNY34.21M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
348.40%vs Conglomerates peers
Operating Cash Flow (TTM)
-1.24BCNY-185.67M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-1.48BCNY-220.69M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1300CNYUpdated Sep 19, 2026Trailing Annual Dividend Yield
2.11%vs all stocks
5-Year Average Dividend Yield
4.46%vs all stocks
Payout Ratio
44.83%vs Conglomerates peers
Minority Interest (Equity)
3.86BCNYFY2025 · Dec 31, 2025Revenue
235.50BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
233.30BCNYFY2025 · Dec 31, 2025Gross Profit
2.20BCNYFY2025 · Dec 31, 2025Operating Income
1.09BCNY162.99M · vs all stocks (USD)
Pre-tax Income
958.64MCNYFY2025 · Dec 31, 2025Income Tax Expense
342.92MCNYFY2025 · Dec 31, 2025Net Income
615.72MCNYFY2025 · Dec 31, 2025EBIT
1.32BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.66BCNYFY2025 · Dec 31, 2025Research & Development
31.41MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
215.13MCNYFY2025 · Dec 31, 2025Other Operating Expenses
242.68MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
35.30MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
357.85MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
856.60MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
856.60MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
615.72MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-393.00MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-1.87BCNYFY2025 · Dec 31, 2025Free Cash Flow
-2.16BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
6.06BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
615.72MCNYFY2025 · Dec 31, 2025Other Non-cash Items
441.16MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-1.41BCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-1.51BCNYFY2025 · Dec 31, 2025Capital Expenditures
-290.95MCNYFY2025 · Dec 31, 2025Net Acquisitions
48.77MCNYFY2025 · Dec 31, 2025Purchase of Investments
-23.32BCNYFY2025 · Dec 31, 2025Sale of Investments
22.60BCNYFY2025 · Dec 31, 2025Other Investing Activity
48.77MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-912.72MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
46.86BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-44.74BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-516.87MCNYFY2025 · Dec 31, 2025Other Financing Charges
982.81MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
2.58BCNYFY2025 · Dec 31, 2025Shares Outstanding
709.66MSharesUpdated Sep 19, 2026Float Shares
308.23MSharesUpdated Sep 19, 2026% Held by Insiders
52.92%vs all stocks
% Held by Institutions
1.08%vs all stocks
Total Cash (MRQ)
8.52BCNY1.27B · vs all stocks (USD)
Total Cash per Share (MRQ)
12.00CNYUpdated Sep 19, 2026Total Debt (MRQ)
16.53BCNY2.47B · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.51xvs Conglomerates peers
Current Ratio (MRQ)
1.25xvs Conglomerates peers
Book Value per Share (MRQ)
6.91CNYUpdated Sep 19, 2026Total Assets
41.74BCNY6.23B · vs all stocks (USD)
Total Current Assets
38.49BCNYFY2025 · Dec 31, 2025Total Liabilities
31.12BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.25BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.42BCNYFY2025 · Dec 31, 2025Total Current Liabilities
28.69BCNYFY2025 · Dec 31, 2025Cash
12.77MCNYFY2025 · Dec 31, 2025Cash Equivalents
2.93BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
9.01BCNYFY2025 · Dec 31, 2025Other Short-term Investments
83.14MCNYFY2025 · Dec 31, 2025Accounts Receivable
5.03BCNYFY2025 · Dec 31, 2025Inventory
12.76BCNYFY2025 · Dec 31, 2025Accounts Payable
13.04BCNYFY2025 · Dec 31, 2025Short-term Debt
6.68BCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.26BCNYFY2025 · Dec 31, 2025Long-term Debt
2.23BCNYFY2025 · Dec 31, 2025Common Stock (Book)
709.66MCNYFY2025 · Dec 31, 2025Retained Earnings
2.80BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
10.63BCNY1.59B · vs all stocks (USD)
52-Week Low
4.92CNYUpdated Sep 19, 202652-Week High
6.95CNYUpdated Sep 19, 202652-Week Change
1.15%vs all stocks
Beta
0.5510xvs all stocks
50-Day MA
5.61CNYUpdated Sep 19, 2026200-Day MA
5.88CNYUpdated Sep 19, 2026Avg 10-Day Volume
11.32MSharesUpdated Sep 19, 2026Avg 30-Day Volume
10.18MSharesUpdated Sep 19, 2026Diluted EPS (TTM)
0.2900CNYUpdated Sep 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Three Turnover Ratios Elevated
Collects fast, clears inventory fast, and pays suppliers fast too.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 1.1%, lower than 95% of its Conglomerates peers (median 26.3%)Significant
Gross margin: 0.01Industry median: 0.26Industry P5: 0.04Peers compared: 100
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 34,212,810.108Operating Cash Flow (USD, TTM): -185,674,157.983
Significant cash reserves alongside high leverageNotable
Cash (USD): 1,270,390,020.895Total Debt (USD): 2,466,053,602.468Debt-to-Equity: 1.51
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.62
Altman Z-Score 6.2: safe zoneNotable
Altman Z-Score: 6.20
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Revenue is $37.92B, higher than 95% of all stocks globallySignificant
Revenue (USD): 37,922,790,007.112Global P95: 15,291,475,445.58
Levered free cash flow is -$220.69M, lower than 95% of all stocks globallySignificant
Levered free cash flow (USD): -220,688,525.292Global P5: -202,685,365.334
Companies that share the same coordination system — how they create, deliver, or capture value.
The Oncology Institute Inc.
Tier 1ProductionThroughput-Bound ConversionRuleRisk
Yueyang Xingchang Petrochemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Tianyang New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Shibaura Machine Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Shanghai Sinotec Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sinosteel Luonai Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
TrueLight Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hangzhou Huning Elevator Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Cubic Sensor and Instrument Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Giti Tire Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Xinjiang Hongtong Natural Gas Co. Ltd.
1 interpretationThree Turnover Ratios Elevated
Scorpio Tankers Inc.
1 interpretationThree Turnover Ratios Elevated
Gamestop Corp.
1 interpretationThree Turnover Ratios Elevated